您的位置：
首页
>
农业专利
>
详情页
Crystalline ethyl 4-[4-[(2R)-3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-oxo-2-[[[4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-piperidinyl]carbonyl]oxy]propyl]-1-piperazinyl]-piperidine-1-acetate difumarate
专利权人:
Uwe Joerg Ries;Kathrin Pachur;Sonja Sproll;Ulrike Werthmann
发明人:
Kathrin Pachur,Uwe Joerg Ries,Ulrike Werthmann,Sonja Sproll
申请号：
US12680060
公开号：
US08551987B2
申请日:
2008.09.25
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The invention relates to the novel salts AB of the base A with a physiologically acceptable acid B which is selected from the group consisting of hydrochloric acid, hydrobromic acid, sulfuric acid, fumaric acid and salicylic acid and the polymorphic compounds, the corresponding solvates and hydrates thereof.
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
相关专利
НОВОЕ СОЕДИНЕНИЕ И ЕГО ПРИМЕНЕНИЕ В МЕДИЦИНЕ
New compound and medical use thereof
Quaternary salt of 2,6-bis [4,6-dimethoxypyrimidin-2-yl)oxy]benzoic acid
ЭТИЛОВЫЕ ЭФИРЫ 4-АРИЛ-ОКСИ-СОРБИНОВОЙ КИСЛОТЫ, ПРОЯВЛЯЮЩИЕ ГЕРБИЦИДНУЮ АКТИВНОСТЬ
4 - {[4 - ({[4- (2,2,2-trifluoroethoxy) -1,2-benzisoxazol-3-yl] oxy} methyl) piperidin-1-yl] methyl} -tetrahydroic acid polymorphic form 2h-pyran-4-carboxylic acid, 4 - {[4 - ({[4- (2,2,2-trifluoroethoxy) -1,2-benzisoxazol-3-yl] oxy} methyl) piperidine acid 1-yl] methyl} -tetrahydro-2h-pyran-4 carboxylic acid, use and process, and method for treating disease conditions mediated by 5-ht4 receptor activity
